Otonomy Reports Second Quarter 2019 Financial Results and Provides Corporate Update

Back to Jobs

Clinical-stage programs on track with results expected from three trials in 2020 Current capital funds operations into 2021 Conference call and webcast today at 4:30 p.m. EDT SAN DIEGO , Aug. 01, 2019 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the

Apply Now